Swiss labs ROCHE (CHF 29.5 bn turnover in 2004, workforce of 65,000 in 150 countries) has bought up GLYCART BIOTECHNOLOGY, a privately owned Swiss biotech company producing technology to enhance the efficacy of antibodies, for CHF 235 mil.